These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Korean biotechs seize opportunity to list on public markets. Louët S Nat Biotechnol; 2005 Oct; 23(10):1189-90. PubMed ID: 16211042 [No Abstract] [Full Text] [Related]
8. The rise of European venture capital for biotechnology. Howell M; Trull M; Dibner MD Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356 [No Abstract] [Full Text] [Related]
9. Biotech financing retrenches in Q2. Lawrence S Nat Biotechnol; 2006 Aug; 24(8):883. PubMed ID: 16900116 [No Abstract] [Full Text] [Related]
10. IPO plans sour on both sides of the pond. Mitchell P Nat Biotechnol; 2004 Aug; 22(8):929-30. PubMed ID: 15286629 [No Abstract] [Full Text] [Related]
12. Looking at US versus European exit opportunities. Lawrence S Nat Biotechnol; 2005 Oct; 23(10):1203. PubMed ID: 16302294 [No Abstract] [Full Text] [Related]